Sunshine Biopharma Inc. (SBFM) Total liabilities 2017–2025
Sunshine Biopharma Inc. (SBFM) total liabilities at each fiscal year-end, per SEC filings.
$7.0MFY2025 · since FY2017: $830,848 → $7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.0M | -0.3% |
| FY2024 | $7.1M | +15.0% |
| FY2023 | $6.1M | -19.4% |
| FY2022 | $7.6M | +282.5% |
| FY2021 | $2.0M | -0.5% |
| FY2020 | $2.0M | +140.0% |
| FY2019 | $833,527 | -30.7% |
| FY2018 | $1.2M | +44.7% |
| FY2017 | $830,848 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFM financial trends
SBFM RevenueSBFM Net incomeSBFM Net marginSBFM Gross profitSBFM Gross marginSBFM Operating incomeSBFM Operating marginSBFM Operating cash flowSBFM Free cash flowSBFM Capital expendituresSBFM Return on equitySBFM Stock buybacksSBFM Dividends paidSBFM Total assetsSBFM Shareholders’ equitySBFM overview →